Indian Journal of Pharmacology Medknow Publications on behalf of Indian Pharmacological Society ISSN: 0253-7613 EISSN: 1998-3751 Vol. 42, Num. 3, 2010, pp. 197-198

Indian Journal of Pharmacology, Vol. 42, No. 3, May-June, 2010, pp. 197-198

Letter To Editor

Authors' reply

Richa Vaishya, J. Singh¹, Harbans Lal

Departments of Biochemistry and ¹ Pharmacology, Pt. BD Sharma Postgraduate Institute of Medical Science, Rohtak, Haryana, India

Correspondence Address: Dr. Richa Vaishya, Department of Biochemistry, Pt. BD Sharma Postgraduate Institute of Medical Science, Rohtak, Haryana, India, richarahu@yahoo.com

Code Number: ph10058

Sir,

We thank Dr. Mahajan for his comments ^[1] on our paper. ^[2] Our reply to the queries are as follows:

1. The study was planned to focus the beneficial effects of irbesartan in comparison to insulin and thus the relevance of the study remains clear.
2. Suggestion at 2 is well-taken for future studies.
3. We regret the typing error; please read group III for insulin and group IV for irbesartan.
4. It is a printing error. The original [Table - 1] and [Table - 3] submitted to the journal office are reproduced here.

References

Copyright 2010 - Indian Journal of Pharmacology

The following images related to this document are available:

Photo images